Srini Tallapragada has a metric he uses to measure whether AI is actually working in an enterprise. It’s not how many tokens the model processes. It’s not benchmark scores or YouTube demos showing how ...

Compounding structural issues plague emerging countries, limiting their access to computing and thereby their participation in the AI economy.

Forbes contributors publish independent expert analyses and insights. Dara-Abasi Ita covers AI in boring asset classes. “Trust is the product, humans are the differentiator,” Alex Wolkomir, a partner ...

Studies reveal the causes of AI sycophancy—and possible fixes ...

Artificial intelligence (AI) is transforming the pharmaceutical industry, revolutionising drug discovery and approval processes, and reshaping how researchers identify potential drug candidates, ...

Bloomfire reports on 6 key knowledge management trends for 2026, emphasizing dynamic collective intelligence as a strategic asset.

Researchers around the world are attempting to create a safer and more effective treatment in hopes of saving hundreds of thousands of lives ...

The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike. Following a turbulent period marked by Brexit and the ...

Meanwhile, the clash between Anthropic and the US Department of Defense continues to unfold. The AI startup filed a lawsuit ...